Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2025-12-26 @ 2:55 AM
NCT ID: NCT01731002
Description: None
Frequency Threshold: 5
Time Frame: 28 Days
Study: NCT01731002
Study Brief: Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
AR-13324 Ophthalmic Solution 0.02% 1 drop to study eye once daily (QD) in the evening (PM) 0 None 0 72 45 72 View
AR-13324 Ophthalmic Solution 0.01% 1 drop to study eye once daily (QD) in the evening (PM) 1 None 1 75 43 75 View
Latanoprost Ophthalmic Solution 0.005% 1 drop to study eye once daily (QD) in the evening (PM) 0 None 2 77 18 77 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Pneumonia Streptococcal SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (15.1) View
Fall SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (15.1) View
Acute Leukaemia SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA (15.1) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Conjunctival Hyperaemia SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (15.1) View
Ocular Hyperaemia SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (15.1) View
Lacrimation Increased SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (15.1) View
Conjunctival Haemorrhage SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (15.1) View
Foreign Body Sensation in Eyes SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (15.1) View
Instillation Site Pain SYSTEMATIC_ASSESSMENT General disorders MedDRA (15.1) View